| scholarly article | Q13442814 |
| review article | Q7318358 |
| meta-analysis | Q815382 |
| P2093 | author name string | Ping Yang | |
| Tao Huang | |||
| Si Chen | |||
| Chao Ni | |||
| Jinyun Li | |||
| Meng Ye | |||
| Ying Ying | |||
| Chongchang Zhou | |||
| P2860 | cites work | Screening for breast cancer with mammography | Q24202273 |
| Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? | Q26775413 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Screening for Colorectal Cancer | Q28005564 | ||
| Role of TET enzymes in DNA methylation, development, and cancer | Q28068541 | ||
| 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage | Q28145962 | ||
| Quantitative synthesis in systematic reviews | Q29614894 | ||
| Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression | Q30769366 | ||
| Promoter-region hypermethylation and gene silencing in human cancer | Q33913606 | ||
| Letter: Nomogram for Bayes theorem | Q34082646 | ||
| The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data | Q34277400 | ||
| Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer | Q35138892 | ||
| Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients | Q35160337 | ||
| High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer | Q35759154 | ||
| The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases | Q35984390 | ||
| CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis | Q36135645 | ||
| Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients | Q36529431 | ||
| Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer | Q37109790 | ||
| Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment. | Q37222882 | ||
| Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer. | Q37588356 | ||
| Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer | Q37641812 | ||
| Epigenetic modifications in prostate cancer | Q38261747 | ||
| CpG island hypermethylation as a biomarker for the early detection of lung cancer | Q38271077 | ||
| Ultrasound screening of contralateral breast after surgery for breast cancer | Q38431268 | ||
| Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin | Q38590710 | ||
| Optimizing Digital Mammographic Image Quality for Full-Field Digital Detectors: Artifacts Encountered during the QC Process | Q38631760 | ||
| Blood-Based Screening for Colon Cancer: A Disruptive Innovation or Simply a Disruption? | Q39681529 | ||
| 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence. | Q39818854 | ||
| Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma | Q39892336 | ||
| Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. | Q40534583 | ||
| Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma | Q40842637 | ||
| Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis | Q41163984 | ||
| Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients | Q43229634 | ||
| A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic-summary point estimates | Q44419258 | ||
| Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified | Q44570474 | ||
| Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker | Q46375432 | ||
| Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis | Q46950071 | ||
| Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis. | Q50585511 | ||
| Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients. | Q51733621 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. | Q53599894 | ||
| Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer. | Q54198320 | ||
| DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients. | Q54303001 | ||
| Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions | Q61758623 | ||
| Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer | Q74088944 | ||
| Hypermethylation of tumor suppressor genes BRCA1, p16 and 14-3-3sigma in serum of sporadic breast cancer patients | Q79692292 | ||
| [Biomarkers in breast cancer] | Q80376591 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | promoter | Q224093 |
| exoribonuclease | Q3062052 | ||
| biomarker | Q864574 | ||
| DNA methylation | Q874745 | ||
| cell-free tumour DNA | Q19596321 | ||
| breast neoplasm | Q23929670 | ||
| 14-3-3 protein | Q24780194 | ||
| tumor biomarker | Q66205818 | ||
| molecular diagnostic techniques | Q69527481 | ||
| cancer diagnosis | Q110324059 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 9230-9242 | |
| P577 | publication date | 2016-12-16 | |
| 2017-02-07 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis | |
| P478 | volume | 8 |
| Q55087346 | Clinical and Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Melanoma: A Systematic Meta-Analysis. |
| Q42362790 | Clinical significance of p16INK4A and p14ARF promoter methylation in renal cell carcinoma: a meta-analysis |
| Q33603685 | Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma |
| Q58698521 | Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients |
| Q51737212 | Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA). |
| Q89967718 | Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection |
| Q41049866 | Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA. |
| Q47146471 | Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection |
| Q42365269 | Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis |
| Q92183923 | The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma |
| Q41933719 | p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA). |
Search more.